GoodRx Fined $1.5 Million for Disclosure of Users’ Personal Information to Third Parties Without Notice or Consent
On February 1, 2023, the Federal Trade Commission (FTC) filed a “first of its kind” enforcement action under the FTC’s Health Breach Notification Rule, 16 CFR Part 318, which offers several useful takeaways for all companies that collect and process a consumer’s personal information – not just companies that handle health-related data. The FTC’s proposed order seeks to impose a $1.5 million civil penalty against GoodRx, a digital health platform, for sharing the sensitive personal health and other information of millions of GoodRx users with various advertising platforms, including Facebook and Google, and failing to report these disclosures to consumers. According to the FTC complaint, GoodRx collects sensitive personal information from users and represents that it will treat users’ information in accordance with its privacy policies. Since at least 2017, the GoodRx privacy policy specifically stated that GoodRx “would never disclose personal health information to advertisers or any third parties.” Yet for several years, GoodRx allegedly violated these promises “by sharing information with Advertising Platforms, including Facebook, Google and Criteo, about users’ prescription medications or personal health conditions” and “did so without notice to users, and without obtaining consent.” In addition, GoodRx monetized the personal health information it collected through the creation of advertising campaigns on Facebook and Instagram that targeted GoodRx users. In August...